Figure 3.
(A) Verification of GC and anti-plasminogen (PLG) by Western blotting. Volume represents band intensity band determined by Image Quant QL software: AT0 (group treated with somatropin, at baseline), AT1 (group treated with somatropin at 6 month), BT0 (group treated with placebo, at baseline), and BT1 (group treated with placebo at 6 months). (B) Verification of ITIH4, APOAI, and C4B by selected reaction monitoring. AT0 (group treated with GH, at baseline time). AT1 (group treated with GH at 6 months), BT0 (group treated with placebo, at baseline), BT1 (group treated with placebo at 6 months).
